Summit Therapeutics Inc. (SMMT)
NASDAQ·Healthcare·Biotechnology
$21.37
-3.39%
Mkt Cap $20.45B
Analyst Ratings
Buy
3
Hold
2
Sell
0
Price Target (18 analysts)
$26.00
Range $16.00 – $40.00
Implied Upside
+21.7%
Consensus $26.00 vs current $21.37
NASDAQ·Healthcare·Biotechnology
$21.37
-3.39%
Mkt Cap $20.45B
Buy
3
Hold
2
Sell
0
Price Target (18 analysts)
$26.00
Range $16.00 – $40.00
+21.7%
Consensus $26.00 vs current $21.37